Use access key #2 to skip to page content.
  • S&P 500: 1,070.52
  • Change: 1.30%
$2.82 0.08 (2.92%)
2/9/2010 4:00 PM

SuperGen, Inc. (SUPG)

CAPS Rating:
*****

A pharmaceutical company dedicated to the discovery, development and commercialization of therapies to treat patients with cancer.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating SUPG

Add Stock to Watchlist

What the Community Thinks

Total Members

197 Outperforms
8 Underperforms
 

All-Stars

50 Outperforms
2 Underperforms
 

Wall Street

4 Outperforms
1 Underperforms
 

Members bullish on SUPG are also bullish on:

Members bearish on SUPG are also bearish on:

Ticker Tags

Healthcare (711), Pharmaceuticals (149), Micro Cap (4701), Defensive (1457)
Suggest a tag

SuperGen, Inc. At A Glance

Current Price: $2.82
Last Trade Time: 2/9/2010 4:00 PM
Open: $0.00
Previous Close: $2.74
Daily Range: $2.72 - $2.83
52-Week Range: $1.54 - $3.30
Volume: 803,943
Market Cap: $169.60M
P/E Ratio: 7.30
Compare Our Special Broker Offers!

Stock Trends

SUPG VS S&P 500 (SPY)

News & Discussion Boards

Top Bull Pitch

Recs

1

SuperGen, Inc. (SUPG)

Avatar smitty012 (68.34) Submitted: 1/12/07 5:17 PM

TradingMarkets.com:
Low-Priced Stocks Ready to Surge: These are the stocks under $10/share that today made new 10-day lows that are still in an uptrend as they are trading above their 200-day moving average. They are sorted in rank according to how over-extended they are vs. their 10-day moving av...More

Replies: 0 | Reply | Permalink

Top Bear Pitch

Recs

1

SuperGen, Inc. (SUPG)

Avatar zzlangerhans (99.64) Submitted: 12/01/08 10:09 AM

I lost my bet that Dacogen would show a survival benefit similar to Vidaza. I find the rebound in Supergen stock inexplicable given an absence of positive catalysts. I expect that losses will continue to widen as Dacogen loses market share and the company is forced to expend more resources on their ...More

Replies: 0 | Reply | Permalink

CAPS Members

picks per page. CHANGE

Results 1 - 5 of 26 :   1 2 3 4 5 Next »

Recs

0

 (SUPG)

Avatar EclecticRecluse (74.33) Submitted: 2/09/10 1:27 PM : Outperform Start Price: $2.72 SUPG Score: 3.84

Improving Professional Opinion

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (SUPG)

Avatar craigt101 (64.48) Submitted: 11/25/09 5:40 PM : Outperform Start Price: $2.74 SUPG Score: 6.39

Well heeled, financially...a comfortable moat...provides lots of room for R&D without feeling the pinch. Management appears to have built and strong model for developing cancer and related therapies that cover a broad spectrum of life-threatening diseases. I originally bought in at $2.22 and will give it several years. Who knows...maybe a buyout is down the line, as well.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (SUPG)

Avatar yooperking (94.19) Submitted: 11/17/09 1:05 PM : Outperform Start Price: $2.78 SUPG Score: 4.79

A well capitalized bio tech company with potential that's trading not much more than its cash per share.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (SUPG)

Avatar libertybrewcity (< 20) Submitted: 11/02/09 5:13 PM : Outperform Start Price: $2.37 SUPG Score: 15.63

lots of cash, pipeline with good potential

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (SUPG)

Avatar topsecret10 (81.95) Submitted: 10/13/09 6:32 PM : Outperform Start Price: $2.56 SUPG Score: 11.54

Lots of Insider buying here..... SuperGen is a pharmaceutical company whose mission is to prolong, improve the quality of and ultimately, save the lives of those people afflicted with life-threatening diseases, especially cancer.
The company possesses a broad portfolio of proprietary cancer therapies that target a variety of solid tumors, hematological malignancies and blood disorders, offering renewed hope to patients who suffer from these illnesses.
The company is led by a seasoned management team with extensive experience in all aspects of the oncology pharmaceutical industry. TS

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 26 :   1 2 3 4 5 Next »

Wall Street

Results 1 - 5 of 5  

picks per page. CHANGE

Top
Pick
Member NameMember RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackMerriman < 20 03/31/09 Outperform NS $1.75+61.14%+36.17%+24.97
TrackRodmanRen < 20 07/02/08 Outperform NS $2.15+31.16%-14.19%+45.36
TrackSusquehanna 74.67 07/02/08 Outperform NS $2.15+31.16%-14.19%+45.36
TrackBroadpoint.AmTech 76.97 09/05/07 Outperform NS $4.19-32.70%-23.76%-8.94
TrackJimCramer < 20 08/03/07 Underperform 3W $5.04-44.05%-21.54%+22.51

Results 1 - 5 of 5  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners

EQWEBD01 390ms